Table 2 Description of lung function and cardiovascular disease across cohort
From: Lung function and atherosclerosis: a cross-sectional study of multimorbidity in rural Uganda
Disease measure | Total cohort (n = 265) | HIV+ (n = 140) | HIV− (n = 125) | p value* |
|---|---|---|---|---|
FEV1 (L) | 2.47 (2.07, 2.95) | 2.40 (2.08, 2.95) | 2.52 (2.04, 2.95) | 0.853 |
FVC (L) | 3.14 (2.66, 3.70) | 3.09 (2.67, 3.76) | 3.24 (2.66, 3.68) | 0.936 |
FEV1/FVC | 0.80 (0.76, 0.83) | 0.8 (0.75, 0.83) | 0.8 (0.77, 0.83) | 0.671 |
COPD (FEV1/FVC < 0.7) | 17 (6%) | 13 (9%) | 4 (3%) | 0.044 |
cIMT (mm) | 0.67 (0.6, 0.74) | 0.65 (0.59, 0.74) | 0.68 (0.62, 0.74) | 0.076 |
cIMT ≥ 75th percentile | 67 (25%) | 35 (25%) | 32 (26%) | 0.911 |